<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792089</url>
  </required_header>
  <id_info>
    <org_study_id>193/11</org_study_id>
    <nct_id>NCT01792089</nct_id>
  </id_info>
  <brief_title>Fructose-induced Intestinal de Novo Lipogenesis</brief_title>
  <acronym>FIDNL</acronym>
  <official_title>Measure of Intestinal Lipogenesis in Healthy Volunteers and Obese Subjects Before and After Gastroplasty: Modulation by Glucose and Fructose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      8 healthy volunteers, 8 pre-bypass obese subjects, 8 subjects between 12-18 months
      post-bypass, and 8 subjects matched to the post-bypass patients will be studied after
      ingestion of two or three different of the following test-meals: A)cream and whey protein
      B)cream, whey protein and fructose + 13C6 fructose C)test meal with cream, whey protein,
      fructose and glucose + 13C6 fructose Their intestinal de novo lipogenesis will be estimated
      by measuring 13C-palmitate on triglyceride-rich lipoprotein particles associated with apoB48
      in blood
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intestinal de novo lipogenesis</measure>
    <time_frame>0-8-hour post-prandial</time_frame>
    <description>Measurement of total TG and 13C palmitate in chylomicrons: The sf &gt;20 fraction of post-prandial blood samples will be prepared, and non-chylomicrons, apoB100-containing lipoprotein will be removes by immuno-affinity chromatography using a specific anti-apoB100 antibody</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post-prandial triglyceride profile</measure>
    <time_frame>0-8 hour post-prandial</time_frame>
    <description>Triglyceride will be measured in the chylomicron, VLDL, LDL and HDL fractions of post-prandial blood samples</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">24</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>non-obese healthy subjects</arm_group_label>
    <description>subjects with BMI&lt;25 and no known disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>post-gastric bypass</arm_group_label>
    <description>post-obese subjects 12-18 months after Roux-en-Y gastric bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>matched control subjects</arm_group_label>
    <description>Nonobese, healthy subjects of similar age, weight, and gender ratio, than post-bypass subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fat+protein meal</intervention_name>
    <description>cream+ whey protein</description>
    <arm_group_label>non-obese healthy subjects</arm_group_label>
    <arm_group_label>post-gastric bypass</arm_group_label>
    <arm_group_label>matched control subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fat + protein + fructose meal</intervention_name>
    <description>cream+ whey protein + fructose</description>
    <arm_group_label>non-obese healthy subjects</arm_group_label>
    <arm_group_label>post-gastric bypass</arm_group_label>
    <arm_group_label>matched control subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fat+protein+fructose+glucose meal</intervention_name>
    <description>Cream + whey protein + glucose:fructose mixture</description>
    <arm_group_label>non-obese healthy subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        8 non-obese healthy male and female subjects with BMI &lt;25 8 obese male and female subjects
        with BMI&gt; 35 8 post-gastric bypass male and female subjects 8 healthy subjects matched to
        post-gastric bypass subjects for age, gender and weight
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-50 years

          -  sex male or female

          -  less than 2 kg body weight change over the past 3 months subjects

        Exclusion Criteria:

          -  antidiabetic and hypolipemic drugs

          -  alcohol consumption &gt;20g/day

          -  severe eating disorders

          -  severe psychological problems

          -  vegetarian diet or other specific diet

          -  consumption of illicit substances

          -  pregnancy

          -  weight gain or weight loss &gt; 1 kg in the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>VD</state>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2013</study_first_submitted>
  <study_first_submitted_qc>February 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>June 3, 2014</last_update_submitted>
  <last_update_submitted_qc>June 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>de novo lipogenesis</keyword>
  <keyword>fructose</keyword>
  <keyword>roux-en-Y gastric bypass</keyword>
  <keyword>post-prandial triglycerides</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

